APA (7th ed.) Citation

P, B., C, A., G, E., A, D., F, d., P, S., . . . A, M. (2025). A 24-week prospective, multicenter, real-world study on eptinezumab's effectiveness and safety in migraine prevention (EMBRACE II). Journal of neurology, 272(6), 382. https://doi.org/10.1007/s00415-025-13095-z

Chicago Style (17th ed.) Citation

P, Barbanti, et al. "A 24-week Prospective, Multicenter, Real-world Study on Eptinezumab's Effectiveness and Safety in Migraine Prevention (EMBRACE II)." Journal of Neurology 272, no. 6 (2025): 382. https://doi.org/10.1007/s00415-025-13095-z.

MLA (9th ed.) Citation

P, Barbanti, et al. "A 24-week Prospective, Multicenter, Real-world Study on Eptinezumab's Effectiveness and Safety in Migraine Prevention (EMBRACE II)." Journal of Neurology, vol. 272, no. 6, 2025, p. 382, https://doi.org/10.1007/s00415-025-13095-z.